FIELD: medicine.
SUBSTANCE: present invention relates to the field of medicine, namely to the use of polymerized hemoglobin in the form of lyophilizate for the preparation of a solution for infusions as an agent increasing an effect of chemotherapeutic drugs in the treatment of brain tumors.
EFFECT: present invention provides expansion of the arsenal of remedies simultaneously having oxygen-transport, phase-modulating, and chemo-modifying properties at low concentrations and doses of administration of polymerized hemoglobin.
1 cl, 2 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| REMEDY WITH ANTI-TUMOR EFFECT FOR TREATMENT OF ONCOLOGICAL DISEASES | 2018 |
|
RU2761429C2 |
| AGENT FOR BLOOD CELL PROTECTION AND HEMATOPOIETIC SYSTEM RESTORATION AND PHARMACOLOGICAL COMBINATION FOR TREATMENT OF ONCOLOGIC PATIENTS | 2007 |
|
RU2328304C1 |
| MEANS OF SIMULTANEOUS PROTECTIVE ACTION IN RELATION TO HEALTHY ORGANS AND TISSUE AND ADJUVANT ACTION IN RADIO AND CHEMOTHERAPY OF TUMOURS | 2015 |
|
RU2646497C2 |
| SOLUTION THAT HAVE ANTIPROLIFERATIVE AND ANTIMETASTATIC PROPERTIES FOR ONCOLOGICAL DISEASES TREATMENT | 2016 |
|
RU2678769C2 |
| USE OF POLYMERIZED HEMOGLOBIN FOR MOBILIZATION OF BLOOD FROM DEPOT IN CASE OF BLOOD LOSS | 2021 |
|
RU2811253C2 |
| HEMATOPOIETIC PRECURSOR CELL DIFFERENTIATION INHIBITOR | 2006 |
|
RU2317074C1 |
| METHOD OF COMBINED THERAPY FOR CONNECTIVE TISSUE SARCOMA M-1 IN RATS USING A CONJUGATE OF DIPROPOXYBACTERIOPURPURIN WITH DOXORUBICIN | 2023 |
|
RU2808909C1 |
| USE OF COMPLEX OF 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE WITH β-CYCLODEXTRIN FOR CORRECTION OF SPERMATOGENESIS DISORDERS CAUSED BY CYTOTOXIC EFFECT | 2019 |
|
RU2782758C2 |
| DITHIOCARBAMATE DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND AGENT FOR TREATING OR PREVENTING TUMOUR DISEASES CONTAINING SAID DERIVATIVE | 2011 |
|
RU2502731C2 |
| USE OF PHARMACEUTICAL COMPOSITION OF β-CYCLODEXTRIN WITH 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE FOR INCREASING/RESTORING LIBIDO | 2019 |
|
RU2782133C2 |
